Is Insulin Glargine (Lantus) Associated with Increased Risk of Cancer? | diabetes
Links shared publicly online about this topic.
- 32total visits
Is Insulin Glargine (Lantus) Associated with Increased Risk of Cancer? | diabetes
View full resource at diabeticlive.com
Tags: Diabetes, Diabetes Type 1 Medication, Diabetes Type 2 Medication, Diabetes Medication, Insulin, Cancer, Lantus
Most Recently Shared on August 31, 2011 at 1:11 pm By:
Is Insulin Glargine (Lantus) Associated with Increased Risk of Cancer? http://t.co/SS3k69G
FDA determines no cancer risk associated with Lantus - MPR
empr.com — “At this time, the FDA has concluded that Lantus (insulin glargine [recombinant], from sanofi-aventis) does not increase the risk of cancer.” View full resource at empr.com
Most Recently Shared on January 25, 2011 at 4:23 pm By:
MPR News: FDA determines no cancer risk associated with Lantus: At this time, the FDA has concluded that Lantus ... http://bit.ly/ftLZYS
FDA determines no cancer risk associated with Lantus - ONA
oncologynurseadvisor.com — “At this time, the FDA has concluded that Lantus (insulin glargine [recombinant], from sanofi-aventis) does not increase the risk of cancer.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 25, 2011 at 3:48 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
FDA determines no cancer risk associated with Lantus http://goo.gl/fb/26fJr
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
fda.gov — “[1-12-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of Lantus (insulin glargine) and a possible increased risk of cancer.” View full resource at fda.gov
Most Recently Shared on January 13, 2011 at 2:37 pm By:
NCI Cancer Bulletin Health News
FDA provides update on review of possible link between diabetes drug, cancer risk: http://bit.ly/hVDraB
Medical News: FDA Still Uncertain About Lantus Cancer Risk - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Eighteen months after starting a probe of potential cancer risks associated with insulin glargine (Lantus), the FDA still hasn't decided whether the concern is justified, the agency said.” View full resource at medpagetoday.com
Most Recently Shared on January 12, 2011 at 10:36 pm By:
FDA Still Uncertain About Lantus Cancer Risk http://bit.ly/exWVO3
Study to determine link between insulin glargine and cancer
news-medical.net — “Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications. However, these studies were unable to control for important factors such as obesity that may have driven the association.” View full resource at news-medical.net
Most Recently Shared on December 15, 2009 at 6:58 pm By:
Obesity News: Study to determine link between insulin glargine and cancer: Type 2 diabetes and obesity are linked... http://twurl.nl/bn1x0l
Medical News: EASD: Insulin Analogues, Cancer Linked, but No Causality Shown - in Meeting Coverage, EASD from MedPage Today
medpagetoday.com — “VIENNA -- Patients taking insulin-based drugs for diabetes appear prone to increased rates of cancer diagnosis, but there appears to be no special risk for insulin glargine (Lantus) compared with othe” View full resource at medpagetoday.com
Most Recently Shared on September 30, 2009 at 8:58 pm By:
Patients receiving insulin-based agents appear more likely to be diagnosed with cancer. More: http://bit.ly/2lxnxe
Medical News: EASD: Insulin Analogues, Cancer Linked, but No Causality Shown - in Meeting Coverage, EASD from MedPage Today
medpagetoday.com — “VIENNA -- Patients taking insulin-based drugs for diabetes appear prone to increased rates of cancer diagnosis, but there appears to be no special risk for insulin glargine (Lantus) compared with othe” View full resource at medpagetoday.com
Most Recently Shared on September 30, 2009 at 6:39 pm By:
EASD: Insulin Analogues, Cancer Linked, but No Causality Shown http://bit.ly/bTpZb
Medical News: Mixed Message on Insulin Glargine Cancer Risk - in Cardiovascular, Diabetes from MedPage Today
medpagetoday.com — “HOUSTON -- Studies examining a possible cancer link to insulin glargine (Lantus) produced mixed conclusions that drew quick, reassuring messages from diabetes authorities.” View full resource at medpagetoday.com
Most Recently Shared on June 29, 2009 at 11:49 pm By:
CARDIOLOGY• Mixed Message on Insulin Glargine Cancer Risk (CME/CE) http://tinyurl.com/mq2dup
Advertisement
